Toxicity and antibacterial assessment of chitosancoated silver nanoparticles on human pathogens and macrophage cells

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1805-1818

  Jena, Prajna ^a   Mohanty, Soumitra ^a   Mallick, Rojee ^a   Jacob, Biju ^b   Sonawane, Avinash ^a  

^a KIIT UNIVERSITY   (India)

^b Center for Innovation   (India)

Author keywords

Antibiofilm; Chitosan silver nanoparticles; Cytotoxicity; Genotoxicity

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHITOSAN; PROPIDIUM IODIDE; SILVER NANOPARTICLE; ANTIINFECTIVE AGENT; METAL NANOPARTICLE; NANOCOMPOSITE; SILVER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BIOFILM; CELL TRANSPORT; COLONY FORMING UNIT; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA FRAGMENTATION; DRUG EFFECT; DRUG POTENCY; DRUG RESPONSE; ENDOCYTOSIS; GENOTOXICITY; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MACROPHAGE; MYCOBACTERIUM SMEGMATIS; NANOFABRICATION; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; TOXICITY TESTING; ANIMAL; BACTERIUM; CELL LINE; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; MOUSE; NANOMEDICINE; PATHOGENICITY;

BACTERIA (MICROORGANISMS);

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOFILMS; CELL LINE; CHITOSAN; DNA DAMAGE; HUMANS; MACROPHAGES; METAL NANOPARTICLES; MICE; MICROSCOPY, ELECTRON, SCANNING; MYCOBACTERIUM SMEGMATIS; NANOCOMPOSITES; NANOMEDICINE; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 84866765823     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S28077     Document Type: Article

References (47)

1. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83(5):761-769.
2. Hong B, Kai J, Ren Y, et al. Highly sensitive rapid, reliable, and automatic cardiovascular disease diagnosis with nanoparticle fluorescence enhancer and mems. Adv Exp Med Biol. 2008;614:265-273.
3. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83.
4. Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya RH. Functional finishing of cotton fabrics using silver nanoparticles. J Nanosci Nanotechnol. 2007;7(6):1893-1897.
5. Castellano JJ, Shafii SM, Ko F, et al. Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int Wound J. 2007;4(2):114-122.
6. Wei D, Sun W, Qian W, Ye Y, Ma X. The synthesis of chitosan-based silver nanoparticles and their antibacterial activity. Carbohydrate Research. 2009;344(17):2375-2382.
7. Panacek A, Kvitek L, Prucek R, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006;110(33):16248-16253.
8. Sambhy V, MacBride MM, Peterson BR, Sen A. Silver bromide nanoparticle/polymer composites: dual action tunable antimicrobial materials. J Am Chem Soc. 2006;128(30):9798-9808.
9. Kong H, Jang J. Antibacterial properties of novel poly(methyl methacrylate) nanofiber containing silver nanoparticles. Langmuir. 2008;24(5):2051-2056.
10. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52(4):662-668.
11. Kalishwaralal K, BarathManiKanth S, Pandian SR, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf B Biointerfaces. 2010;79(2):340-344.
12. Papageorgiou I, Brown C, Schins R, et al. The effect of nano-and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro. Biomaterials. 2007;28(19):2946-2958.
13. Lu Y, Mei Y, Schrinner M, Ballauff M, Möller MW, Breu J. In situ formation of Ag nanoparticles in spherical polyacrylic acid brushes by UV irradiation. J Phys Chem C. 2007;111(21):7676-7681.
14. Willner I, Baron R, Willner B. Growing metal nanoparticles by enzymes. Adv Mater. 2006;18(9):1109-1120.
15. Mallikarjuna NN, Varma RS. Microwave-assisted shape-controlled bulk synthesis of noble nanocrystals and their catalytic properties. Cryst Growth Des. 2007;7(4):686-690.
16. Chen M, Wang LY, Han JT, Zhang JY, Li ZY, Qian DJ. Preparation and study of polyacryamide-stabilized silver nanoparticles through a one-pot process. J Phys Chem B. 2006;110(23):11224-11231.
17. Lou XW, Yuan C, Archer LA. An unusual example of hyperbranched metal nanocrystals and their shape evolution. Chem Mater. 2006;18(17):3921-3923.
18. Kuo PL, Chen WF. Formation of silver nanoparticles under structured amino groups in pseudo-dendritic poly(allylamine) derivatives. J Phys Chem B. 2003;107(41):11267-11272.
19. Valodkar M, Bhadoria A, Pohnerkar J, Mohan M, Thakore S. Morphology and antibacterial activity of carbohydrate-stabilized silver nanoparticles. Carbohydr Res. 2010;345(12):1767-1773.
20. Jaiswal S, Duffy B, Jaiswal AK, Stobie N, McHale P. Enhancement of the antibacterial properties of silver nanoparticles using beta-cyclodextrin as a capping agent. Int J Antimicrob Agents. 2010;36(3):280-283.
21. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomedicine. 2010;6(1):103-109.
22. Salunkhe RB, Patil SV, Salunke BK, Patil CD, Sonawane AM. Studies on silver accumulation and nanoparticle synthesis by Cochliobolus lunatus. Appl Biochem Biotechnol. 2011;165(1):221-234.
23. Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine. 2007;3(2):168-171.
24. Wang B, Chen K, Jiang S, et al. Chitosan-mediated synthesis of gold nanoparticles on patterned poly(dimethylsiloxane) surfaces. Biomacromolecules. 2006;7(4):1203-1209.
25. Yi H, Wu LQ, Bentley WE, et al. Biofabrication with chitosan. Biomacromolecules. 2005;6(6):2881-2894.
26. Dos Santos DS Jr, Goulet PJ, Pieczonka NP, Oliveira ON Jr, Aroca RF. Gold nanoparticle embedded, self-sustained chitosan films as substrates for surface-enhanced Raman scattering. Langmuir. 2004;20(23):10273-10277.
27. Liu X, Hu Q, Fang Z, Zhang X, Zhang B. Magnetic chitosan nanocomposites: a useful recyclable tool for heavy metal ion removal. Langmuir. 2009;25(1):3-8.
28. Duan W, Shen C, Fang H, Li GH. Synthesis of dehydroabietic acidmodified chitosan and its drug release behavior. Carbohydr Res. 2009;344(1):9-13.
29. Jin X, Wang J, Bai J. Synthesis and antimicrobial activity of the Schiff base from chitosan and citral. Carbohydr Res. 2009;344(6):825-829.
30. Prochazkova S, Vårum KM, Ostgaard K. Quantitative determination of chitosans by ninhydrin. Carbohydr Polym. 1999;38(2):115-122.
31. Gui J, Song Y, Han NL, Sheu FS. Characterization of transcriptional regulation of neurogranin by nitric oxide and the role of neurogranin in SNP-induced cell death: implication of neurogranin in an increased neuronal susceptibility to oxidative stress. Int J Biol Sci. 2007;3(4):212-224.
32. Neumeyer A, Bukowski M, Veith M, Lehr CM, Daum N. Propidium iodide labeling of nanoparticles as a novel tool for the quantification of cellular binding and uptake. Nanomedicine. 2011;7(4):410-419.
33. Sonawane A, Santos JC, Mishra BB, et al. Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Cell Microbiol. 2011;13(10):1601-1617.
34. Liu N, Chen XG, Park HJ, et al. Effect of MW and concentration of chitosan on antibacterial activity of Escherichia coli. Carbohydr Polym. 2006;64(1):60-65.
35. Chung YC, Wang HL, Chen YM, Li SL. Effect of abiotic factors on the antibacterial activity of chitosan against waterborne pathogens. Bioresour Technol. 2003;88(3):179-184.
36. Varma AJ, Deshpande SV, Kennedy JF. Metal complexation by chitosan and its derivatives: a review. Carbohydr Polym. 2004;55(1):77-93.
37. Murugadoss A, Chattopadhyay A. A 'green' chitosan-silver nanoparticle composite as a heterogeneous as well as micro-heterogeneous catalyst. Nanotechnology. 2008;19(1):015603.
38. Basu S, Jana S, Pande S, Pal T. Interaction of DNA bases with silver nanoparticles: assembly quantified through SPRS and SERS. J Colloid Interface Sci. 2008;321(2):288-293.
39. Hauck TS, Ghazani AA, Chan WC. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small. 2008;4(1):153-159.
40. Khan JA, Pillai B, Das TK, Singh Y, Maiti S. Molecular effects of uptake of gold nanoparticles in HeLa cells. Chembiochem. 2007;8(11):1237-1240.
41. Pan Y, Neuss S, Leifert A, et al. Size-dependent cytotoxicity of gold nanoparticles. Small. 2007;3(11):1941-1949.
42. Yen HJ, Hsu SH, Tsai CL. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small. 2009;5(13):1553-1561.
43. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2):279-290.
44. Pernodet N, Fang X, Sun Y, et al. Adverse effects of citrate/ gold nanoparticles on human dermal fibroblasts. Small. 2006;2(6): 766-773.
45. Yang H, Liu C, Yang D, Zhang H, Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol. 2009;29(1):69-78.
46. Desjardins M, Griffiths G. Phagocytosis: latex leads the way. Curr Opin Cell Biol. 2003;15(4):498-503.
47. Jann NJ, Schmaler M, Kristian SA, et al. Neutrophil antimicrobial defense against Staphylococcus aureus is mediated by phagolysosomal but not extracellular trap-associated cathelicidin. J Leukoc Biol. 2009;86(5):1159-1169.